CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential
1. CDNA faces uncertainty due to proposed reimbursement changes impacting its core business. 2. William Blair initiated coverage, highlighting undervaluation and long-term potential. 3. CareDx reported earnings below expectations, raising concerns on near-term growth. 4. Leadership change with Nathan Smith appointed as new CFO. 5. Analysts see potential revenue headwinds but long-term value in CDNA's assets.